Literature DB >> 1740562

Treatment of glabellar frown lines with C. botulinum-A exotoxin.

J D Carruthers1, J A Carruthers.   

Abstract

Eighteen patients with glabellar frown lines were treated with C. botulinum-A exotoxin. Sixteen of the 17 patients followed showed improvement for periods ranging from 3 months to 11 months. Side-effects were minimal and transient. Because C. botulinum-A exotoxin therapy of glabellar frown lines treats the underlying cause of these lines, it is more effective than soft tissue augmentation although this improvement is temporary. Treatment with C. botulinum-A exotoxin is a simple, safe procedure.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1740562     DOI: 10.1111/j.1524-4725.1992.tb03295.x

Source DB:  PubMed          Journal:  J Dermatol Surg Oncol        ISSN: 0148-0812


  39 in total

Review 1.  [Use of botulinum toxin the the treatment of muscle pain].

Authors:  R Benecke; D Dressler; E Kunesch; T Probst
Journal:  Schmerz       Date:  2003-12       Impact factor: 1.107

2.  [Conservative treatment of facial wrinkles in the hands of the plastic surgeon].

Authors:  S Brüner; R Deb; G Germann
Journal:  Chirurg       Date:  2003-09       Impact factor: 0.955

Review 3.  Botulinum toxin drugs: brief history and outlook.

Authors:  D Dressler
Journal:  J Neural Transm (Vienna)       Date:  2015-11-11       Impact factor: 3.575

4.  [Treatment of wrinkles with botulinum toxin].

Authors:  I Lanzl; R-L Merté
Journal:  Ophthalmologe       Date:  2007-09       Impact factor: 1.059

5.  A Phase III Study of IncobotulinumtoxinA in the Treatment of Glabellar Frown Lines.

Authors:  Matthias Imhof; Ulrich Kühne
Journal:  J Clin Aesthet Dermatol       Date:  2011-10

6.  The effect of incobotulinumtoxin a and dermal filler treatment on perception of age, health, and attractiveness of female faces.

Authors:  Bernhard Fink; Michael Prager
Journal:  J Clin Aesthet Dermatol       Date:  2014-01

Review 7.  Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.

Authors:  Marco Pirazzini; Ornella Rossetto; Roberto Eleopra; Cesare Montecucco
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

8.  Botulinum toxin A treatment of overactive corrugator supercilii in thyroid eye disease.

Authors:  J M Olver
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

Review 9.  Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: a review of the science, the clinical data, and patient satisfaction.

Authors:  Koenraad De Boulle; Steven Fagien; Boris Sommer; Richard Glogau
Journal:  Clin Interv Aging       Date:  2010-04-26       Impact factor: 4.458

10.  The use of botulinum toxin as primary or adjunctive treatment for post acne and traumatic scarring.

Authors:  Greg J Goodman
Journal:  J Cutan Aesthet Surg       Date:  2010-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.